Coronavirus (COVID-19) in Latin America - statistics & facts

Beyond a sanitary crisis

The COVID-19 pandemic in Latin America has posed an unprecedented threat within a region already facing multiple challenges. The contingency has reached various socio-economic dimensions and has presented itself as more than a purely sanitary crisis. While the outbreak has negatively impacted the global economy, the result for Latin American households has been overwhelmingly challenging. With GDPs affected and governments limited by budgetary and political constraints, little to no economic support has been offered to citizens. This has resulted in the exacerbation of multiple social issues and a further increase on cases as people desperately seek for income sources as a result of unemployment.

The health crisis itself has also been aggravated by regional constraints. The lack of testing capacity, overcrowded hospitals, and limited resources such as medical oxygen, are some examples of what Latin American patients have been facing throughout the pandemic.

A glimpse of hope: immunization campaigns

As higher-income countries discuss the possibility of applying a second round of booster shots to their already immunized and immunocompromised population, while facing the challenge of those who do not want to get vaccinated, countries in Latin America are still dealing with the constrained acquisition of doses for covering their local demands. Within the region, the immunization process differs from country to country. While more populated nations such as Brazil, Mexico, and Argentina, had already administered millions of doses by the beginning of 2022, Haiti had just applied over 200 thousand for a population surpassing 11 million people. When talking about doses per 100 inhabitants, numbers look different, with Cuba and Chile ranking on top. Which vaccines had been applied and how they have been obtained, also differ from nation to nation. In Chile, for instance, most people have been vaccinated with Sinovac’s COVID-19 vaccine, while in Mexico the most applied one has been that of AztraZeneca. Moreover, while some countries have acquired an important share of their vaccines, others rely heavily on donations, such as those provided under the COVAX program, or by high-income nations.

This text provides general information. Statista assumes no liability for the information given being complete or correct. Due to varying update cycles, statistics can display more up-to-date data than referenced in the text.